RAD 202 receives approval to start Phase 1 therapeutic trial December 20, 2024 Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com admin December 20, 2024
